Active Ingredient: RANOLAZINE
Proprietary Name: RANOLAZINE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 500MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A214035
Product Number: 001
Approval Date: Jan 19, 2022
Applicant Holder Full Name: VKT PHARMA PRIVATE LTD
Marketing Status:
Prescription
Patent and Exclusivity Information